CAS 164656-23-9 Dutasteride

본문 바로가기


Home > Product > CAS 164656-23-9 Dutasteride
Selling leads
CAS 164656-23-9 Dutasteride
Posting date : Jan 10, 2018
Membership
Free Member Scince Jan 09, 2018
FOB Price
negotiable
Min. Order Quantity
10 grams
Supply Abillity
5000kg/month
Port
shenzhen
Payment Terms
Western Union,T/T,Money Gram,Bitcoins
Package
Disguised Package
Keyword :
Category
Contact
Fredeboo
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Daoqi
HS-CODE
-
Package & Delivery Lead Time
Package
Disguised Package
Delivery Lead Time
within 24 hours
Detailed Description
Email:Fredeboo@chembj.comSkype:fredeboo_2Whatsapp:+86 18038709085
Product Name: DutasterideOther name: Duagen; Avodart,Dutas,Dutasteride-13CCAS register number: 164656-23-9Molecular formula: C27H30F6N2O2Molecular weight: 528.53Melting point: 242°C~250°CAssay: 99%Appearance:White crystalline powder 
Dutasteride (trademark name Avodart) is a dual 5-α reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT). Used for benign prostatic hyperplasia; however, it increases the risk of erectile dysfunction and decreased sexual desire.
Dutasteride is useful for the symptoms of benign prostatic hyperplasia (BPH); colloquially known as an "enlarged prostate". In those who are being regularly screened 5-alpha-reductase inhibitor (finasteride and dutasteride) reduce the overall risk of being diagnosed with prostate cancer however there is insufficient data to determine if they have an effect on the risk of death and may increase the chance of more serious cases. 
This class of medications increases rates of erectile dysfunction (with between 5% and 9% developing problems after starting their use). This is linked to lower quality of life and can cause stress in relationships. There is also an association with lowered sexual desire. It has been reported that these adverse sexual side effects may persist even after discontinuation of the drug. 
The FDA has added a warning to dutasteride about an increased risk of high-grade prostate cancer. While the potential for positive, negative or neutral changes to the potential risk of developing prostate cancer with dutasteride has not been established, evidence has suggested it may temporarily reduce the growth and prevalence of benign prostate tumors, but could also mask the early detection of prostate cancer. The primary area for concern is for patients who may develop prostate cancer whilst taking dutasteride for benign prostatic hyperplasia, which in turn could delay diagnosis and early treatment of the prostate cancer, thereby potentially increasing the risk of these patients developing high-grade prostate cancer.
 
Steroid Hormone Powder 
Testosterone Acetate
Trenbolone Acetate
MGF
Testosterone Cypionate
Trenbolone Enanthate
PEG MGF
Testosterone Decanoate
Boldenone Acetate
CJC-1295
Testosterone Enanthate
Boldenone undecylenate
CJC-1295 DAC
Testosterone Isocaproate
Boldenone Cypionate
PT-141
Testosterone Phenylpropionate
Boldenone Propionate
Melanotan-1
Testosterone Propionate
Nandrolone Decanoate
Melanotan-2
Testosterone Undecanoate
Nandrolone phenylpropionate
GHRP-2
Mesterone
Nandrolone undecylate
GHRP-6
Testosterone Sustanon 250
Nandrolone cypionate 
Ipamorelin
Clostebol Acetate
Nandrolone propionate
Hexarelin
Methylandrostanolone
Methyltrienolone
Sermorelin
Methenolone Enanthate
Drostanolone Propionate
Oxytocin
Methenolone Acetate
Drostanolone Enanthate
TB500
Anadrol
Stanolone
Fragment 176-191
Anavar
Tadalafil
Triptorelin
Winstrol
Vardenafil
Tesamorelin
Clomifene citrate
Dianabol
Gonadorelin
Toremifene citrate
Tamoxifen Citrate
DSIP 
Finasteride
 
Selank

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top